In June 2019, Daiichi Sankyo was selected for the first time as a component of the MSCI Japan ESG Select Leaders Index, one of the ESG investment indices adopted by the Government Pension Investment Fund (GPIF). The MSCI Japan ESG Select Leaders Index consists of a selected list of companies with excellent ESG evaluations among the MSCI Japan IMI Top 700 Index.

Daiichi Sankyo has already been selected for the FTSE Blossom Japan Index, the MSCI Japan Empowering Women (WIN) Select Index and the S&P/JPX Carbon Efficient Index in the past. By being selected for the MSCI Japan ESG Select Leaders Index, we have now been selected for all four indices employed by the GPIF for managing Japanese stocks.

Apart from the above indices, we have been selected consecutively for 11 years as a component of the FTSE4Good Index Series, and we are the only Japanese pharmaceutical company to be listed on the DJSI World Index for the second consecutive year.

Going forward, Daiichi Sankyo will continue to boost its corporate value through proactively engaging in initiatives to respond to and resolve social issues, and will strive to contribute toward realizing a sustainable society.